New anesthesia drug could make surgery safer for seniors
NCT ID NCT06690424
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares remimazolam, a newer sedative, to the standard drug propofol for anesthesia in 92 elderly patients (ages 60-75) undergoing thyroid surgery. The goal is to see if remimazolam provides smoother induction, stable vital signs, and faster recovery with fewer complications like confusion or irregular heartbeat. Results could lead to a safer anesthesia choice for older adults.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remimazolam
What this could lead to
If successful, remimazolam could offer a safer anesthesia option for elderly patients, with fewer side effects like low blood pressure or confusion after surgery.
What could go wrong
This is a small, single-center trial with only 92 participants, so results may not apply to all elderly patients. Remimazolam may not prove better than propofol in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFICACY AND SAFETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Affiliated Hospital
Nantong, Jiangsu, 226001, China